Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Matrix Biology : Journal of the International Society for Matrix Biology|January 26, 2016
Matricellular proteins as regulators of cancer metastasis to boneTimothy N Trotter, Yang Yang
The Journal of Organic Chemistry|August 14, 2012
Total synthesis of 7-deoxy-6-O-methylfusarentin featuring a chelation-controlled 1,3-Reetz-Keck-type allylationTimothy N Trotter, Aymara M M Albury, Michael P Jennings
The American Journal of Pathology|September 21, 2016
Adipocyte-Lineage Cells Support Growth and Dissemination of Multiple Myeloma in BoneTimothy N Trotter, Justin T Gibson, Tshering Lama Sherpa, et al.
Molecular Cancer Research : MCR|March 30, 2018
Runx2 Suppression by miR-342 and miR-363 Inhibits Multiple Myeloma ProgressionPramod S Gowda, Benjamin J Wildman, Timothy N Trotter, et al.
Bone|July 31, 2013
Heparanase inhibits osteoblastogenesis and shifts bone marrow progenitor cell fate in myeloma bone diseaseJian Ruan, Timothy N Trotter, Li Nan, et al.
Cancer Research|January 9, 2020
Runx2 Deficiency in Osteoblasts Promotes Myeloma Progression by Altering the Bone Microenvironment at New Bone SitesXiaoxuan Xu, Chao Zhang, Timothy N Trotter, et al.
Oncotarget|February 6, 2016
Heparanase promotes myeloma progression by inducing mesenchymal features and motility of myeloma cellsJuan Li, Qianying Pan, Patrick D Rowan, et al.
Blood|April 12, 2015
Myeloma cell-derived Runx2 promotes myeloma progression in boneTimothy N Trotter, Mei Li, Qianying Pan, et al.
Molecular Cancer Therapeutics|December 15, 2021
Runx2 Deficiency in Osteoblasts Promotes Myeloma Resistance to Bortezomib by Increasing TSP-1-Dependent TGFβ1 Activation and Suppressing Immunity in Bone MarrowChao Zhang, Xiaoxuan Xu, Timothy N Trotter, et al.
JCI Insight|October 17, 2023
Dormant tumors circumvent tumor-specific adaptive immunity by establishing a Treg-dominated niche via DKK3Timothy N Trotter, Carina E Dagotto, Delila Serra, et al.
Pageof 2